Immediate Impact
69 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
Works of Anna Ma being referenced
CA-170, a first in class oral small molecule dual inhibitor of immune checkpoints PD-L1 and VISTA, demonstrates tumor growth inhibition in pre-clinical models and promotes T cell activation in Phase 1 study
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anna Ma | 243 | 150 | 79 | 8 | 362 | |
| Marion Refici | 279 | 131 | 52 | 8 | 352 | |
| Mylissa Borek | 290 | 105 | 43 | 10 | 355 | |
| Jill Piens | 295 | 214 | 80 | 7 | 392 | |
| Michael Röring | 293 | 99 | 71 | 8 | 360 | |
| J Y J Wang | 254 | 230 | 61 | 9 | 390 | |
| Stephen Schmidt | 152 | 83 | 43 | 13 | 322 | |
| Flora Luo | 194 | 100 | 60 | 9 | 374 | |
| Joseph R. Testa | 229 | 82 | 46 | 11 | 363 | |
| Stacy M. Plum | 198 | 103 | 27 | 10 | 345 | |
| Lucy Scott | 246 | 160 | 109 | 7 | 343 |
All Works
Login with ORCID to disown or claim papers
Loading papers...